Author

S. L. Geeraerts

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Voet· 1 shared B. P. A. Cammue· 1 shared B. Verbelen· 1 shared D. Cassiman· 1 shared G. Rinaldi· 1 shared K. De Brucker· 1 shared K. De Cremer· 1 shared K. De Keersmaecker· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Voet

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposing the antidepressant sertraline as SHMT inhibitor to suppress serine/glycine synthesis addicted breast tumor growth.

S. L. Geeraerts, K. R. Kampen, G. Rinaldi, P. Gupta, M. Planque, K. De Cremer, K. De Brucker, S. Vereecke, B. Verbelen, P. Vermeersch, D. Cassiman, S.-M. Fendt, A. Voet, B. P. A. Cammue, K. Thevissen, K. De Keersmaecker

This study repurposes sertraline as an inhibitor of serine hydroxymethyltransferase to target serine/glycine synthesis in breast cancer, showing synergistic antitumor effects with mitochondrial inhibitors.

bioRxiv · Jun 12, 2020Cancer Biology